All In Biotech

Drug Trial Radar · NCT06469151

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults

A Phase I Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacokinetics of AZD5148 in Healthy Adults

Last checked: Nov 19, 2026Latest source record: Nov 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

84

Actual

Start

Jun 24, 2024

Primary completion

Oct 22, 2025

Study completion Oct 22, 2025

Sponsor

Lead sponsor
AstraZenecaAstraZeneca (AZN)
Sponsor type
Industry
First posted
Jun 21, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The purpose of this study is to measure safety, tolerability, and pharmacokinetics (PK) of a single dose of AZD5148 administered via intravenous (IV) bolus or intramuscular (IM) injection in healthy participants

Conditions

  • Healthy Participants

Interventions

  • AZD5148Drug

    Participants will receive AZD5148 (dose 1, dose 2, dose 3 or dose 4) as an IM injection or IV bolus

  • PlaceboDrug

    Participants will receive matching doses of placebo as an IM injection or IV bolus

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of participants with adverse events (AEs).Time frame: From Day -1 to Day 91
  2. Number of participants with serious adverse events (SAEs) and adverse events of special interest (AESIs)Time frame: From Screening (Day -28 to Day -1) to final Follow-up Visit (Day 361 ± 14)

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Research Site

    Anniston, Alabama

  • Research Site

    Glendale, California

  • Research Site

    Baltimore, Maryland

  • Research Site

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.